PA8467601A1 - STREPTOMYCES AVERMITILIS GENE THAT DIRECTS THE AVERMECTIN RELATION B2: B1 - Google Patents
STREPTOMYCES AVERMITILIS GENE THAT DIRECTS THE AVERMECTIN RELATION B2: B1Info
- Publication number
- PA8467601A1 PA8467601A1 PA19998467601A PA8467601A PA8467601A1 PA 8467601 A1 PA8467601 A1 PA 8467601A1 PA 19998467601 A PA19998467601 A PA 19998467601A PA 8467601 A PA8467601 A PA 8467601A PA 8467601 A1 PA8467601 A1 PA 8467601A1
- Authority
- PA
- Panama
- Prior art keywords
- avermectin
- directs
- relation
- streptomyces avermitilis
- gene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A MOLECULAS POLINUCLEOTIDICAS QUE COMPRENDEN SECUENCIAS DE NUCLEOTIDOS QUE CODIFICAN UN PRODUCTO GENICO AVEC, MOLECULAS POLINUCLEOTIDICAS QUE PUEDEN USARSE PARA ALTERAR LA RELACION O CANTIDAD DE AVERMECTINAS DE CLASES 2:1 PRODUCIDAS EN CULTIVOS DE FERMENTACION DE S. AVERMITILIS. LA PRESENTE INVENCION SE REFIERE ADEMAS A VECTORES, CELULAS HOSPEDADORAS Y CEPAS MUTANTES DE S. AVERMITILIS EN LAS QUE EL GEN AVEC SE HA INACTIVADO O MUTADO PARA CAMBIAR LA RELACION O CANTIDAD DE AVERMECTINAS DE CLASES 2:1 PRODUCIDAS.THE PRESENT INVENTION REFERS TO POLYNUCLEOTIDIC MOLECULES WHICH INCLUDE NUCLEOTIDE SEQUENCES CODING A GENETIC PRODUCT AVEC, POLYNUCLEOTIDIC MOLECULES THAT MAY BE USED TO ALTER THE DEVELOPMENT OF THE 2-DEPARTMENT OF CLASSES AVERMECTINAS THE PRESENT INVENTION FURTHER REFERS TO VECTORS, HOSPITAL CELLS AND MUTANT STRAINS OF S. AVERMITILIS IN WHICH THE AVEC GENE HAS BEEN INACTIVATED OR MUTED TO CHANGE THE RATIO OR NUMBER OF CLASS 2: 1 PRODUCTS PRODUCED.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7463698P | 1998-02-13 | 1998-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8467601A1 true PA8467601A1 (en) | 2000-09-29 |
Family
ID=22120706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA19998467601A PA8467601A1 (en) | 1998-02-13 | 1999-01-26 | STREPTOMYCES AVERMITILIS GENE THAT DIRECTS THE AVERMECTIN RELATION B2: B1 |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP1053335A1 (en) |
| JP (2) | JP2002503473A (en) |
| KR (3) | KR100499214B1 (en) |
| CN (2) | CN1297485A (en) |
| AP (1) | AP9901463A0 (en) |
| AR (1) | AR018085A1 (en) |
| AU (1) | AU752343C (en) |
| BG (1) | BG64911B1 (en) |
| BR (1) | BR9907893A (en) |
| CA (2) | CA2320031A1 (en) |
| CO (1) | CO5070698A1 (en) |
| DZ (1) | DZ2720A1 (en) |
| EA (1) | EA003905B1 (en) |
| GT (1) | GT199900014A (en) |
| HN (1) | HN1999000008A (en) |
| HR (1) | HRP20000539A2 (en) |
| HU (1) | HUP0100784A3 (en) |
| IL (2) | IL137610A0 (en) |
| IS (1) | IS5567A (en) |
| MA (1) | MA24760A1 (en) |
| NO (1) | NO20004044L (en) |
| NZ (2) | NZ518657A (en) |
| OA (1) | OA11449A (en) |
| PA (1) | PA8467601A1 (en) |
| PE (1) | PE20000352A1 (en) |
| PL (1) | PL194270B1 (en) |
| SK (1) | SK11722000A3 (en) |
| TN (1) | TNSN99017A1 (en) |
| TW (1) | TW585910B (en) |
| WO (1) | WO1999041389A1 (en) |
| YU (1) | YU50900A (en) |
| ZA (1) | ZA991138B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ518657A (en) * | 1998-02-13 | 2003-10-31 | Pfizer Prod Inc | Streptomyces hygroscopicus directing the ratio of B2:B1 avermectins |
| US6248579B1 (en) * | 1998-02-13 | 2001-06-19 | Pfizer Inc | Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| OA11998A (en) | 1999-08-12 | 2006-04-18 | Pfizer Prod Inc | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins. |
| US7630836B2 (en) | 2001-05-30 | 2009-12-08 | The Kitasato Institute | Polynucleotides |
| EP1476539B1 (en) | 2002-02-12 | 2009-03-25 | Pfizer Products Inc. | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| CN107338210B (en) * | 2017-09-05 | 2021-08-17 | 天津科技大学 | Abamectin streptomycete synthetic medium and preparation method of fermentation liquor thereof |
| CN111269296B (en) * | 2020-03-06 | 2021-11-05 | 山东大学 | nLsA protein, structural gene thereof and application thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE434277B (en) * | 1976-04-19 | 1984-07-16 | Merck & Co Inc | SET TO MAKE NEW ANTIHELMINTICALLY EFFECTIVE ASSOCIATIONS BY CULTIVATING STREPTOMYCS AVERMITILIS |
| US4429042A (en) * | 1978-09-08 | 1984-01-31 | Merck & Co., Inc. | Strain of Streptomyces for producing antiparasitic compounds |
| IN167980B (en) * | 1987-01-23 | 1991-01-19 | Pfizer | |
| ES2054822T3 (en) * | 1987-10-23 | 1994-08-16 | Pfizer | PROCEDURE FOR THE PRODUCTION OF AVERMECTIN AGLICONES AND THEIR CROPS. |
| JPH0747171B2 (en) * | 1988-09-20 | 1995-05-24 | 株式会社東芝 | Rolling mill setting method and device |
| NZ233116A (en) * | 1989-03-31 | 1994-09-27 | Merck & Co Inc | Cloning genes from steptomyces avermitilis for avermectin biosynthesis |
| US5252474A (en) * | 1989-03-31 | 1993-10-12 | Merck & Co., Inc. | Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use |
| JP2888586B2 (en) * | 1990-03-05 | 1999-05-10 | 社団法人北里研究所 | Microorganism for selective production of specific components of avermectin and its selective production method |
| FI942725A (en) * | 1993-12-16 | 1995-06-17 | Pfizer | Genes encoding branched chain alpha-keto acid dehydrogenase complex from Streptomyces avermitilis |
| NZ518657A (en) * | 1998-02-13 | 2003-10-31 | Pfizer Prod Inc | Streptomyces hygroscopicus directing the ratio of B2:B1 avermectins |
-
1999
- 1999-01-25 NZ NZ518657A patent/NZ518657A/en unknown
- 1999-01-25 CN CN99805027A patent/CN1297485A/en active Pending
- 1999-01-25 CN CNA2004100054154A patent/CN1521180A/en active Pending
- 1999-01-25 KR KR10-2000-7008870A patent/KR100499214B1/en not_active IP Right Cessation
- 1999-01-25 SK SK1172-2000A patent/SK11722000A3/en unknown
- 1999-01-25 WO PCT/IB1999/000130 patent/WO1999041389A1/en not_active Application Discontinuation
- 1999-01-25 YU YU50900A patent/YU50900A/en unknown
- 1999-01-25 BR BR9907893-7A patent/BR9907893A/en not_active Application Discontinuation
- 1999-01-25 PL PL99342468A patent/PL194270B1/en not_active IP Right Cessation
- 1999-01-25 KR KR10-2004-7015691A patent/KR20040099389A/en active Search and Examination
- 1999-01-25 CA CA002320031A patent/CA2320031A1/en not_active Abandoned
- 1999-01-25 JP JP2000531570A patent/JP2002503473A/en active Pending
- 1999-01-25 HU HU0100784A patent/HUP0100784A3/en not_active Application Discontinuation
- 1999-01-25 AU AU18878/99A patent/AU752343C/en not_active Ceased
- 1999-01-25 CA CA002521289A patent/CA2521289A1/en not_active Abandoned
- 1999-01-25 NZ NZ505676A patent/NZ505676A/en unknown
- 1999-01-25 IL IL13761099A patent/IL137610A0/en unknown
- 1999-01-25 KR KR10-2004-7008310A patent/KR20040053390A/en active Search and Examination
- 1999-01-25 EA EA200000758A patent/EA003905B1/en not_active IP Right Cessation
- 1999-01-25 EP EP99900270A patent/EP1053335A1/en not_active Withdrawn
- 1999-01-26 PA PA19998467601A patent/PA8467601A1/en unknown
- 1999-02-01 GT GT199900014A patent/GT199900014A/en unknown
- 1999-02-05 HN HN1991000008A patent/HN1999000008A/en unknown
- 1999-02-08 PE PE1999000099A patent/PE20000352A1/en not_active Application Discontinuation
- 1999-02-09 TW TW088102005A patent/TW585910B/en active
- 1999-02-10 DZ DZ990021A patent/DZ2720A1/en active
- 1999-02-10 TN TNTNSN99017A patent/TNSN99017A1/en unknown
- 1999-02-10 MA MA25460A patent/MA24760A1/en unknown
- 1999-02-11 AP APAP/P/1999/001463A patent/AP9901463A0/en unknown
- 1999-02-11 AR ARP990100571A patent/AR018085A1/en unknown
- 1999-02-12 ZA ZA9901138A patent/ZA991138B/en unknown
- 1999-02-12 CO CO99008652A patent/CO5070698A1/en unknown
-
2000
- 2000-07-20 IS IS5567A patent/IS5567A/en unknown
- 2000-08-04 OA OA1200000217A patent/OA11449A/en unknown
- 2000-08-11 HR HR20000539A patent/HRP20000539A2/en not_active Application Discontinuation
- 2000-08-11 NO NO20004044A patent/NO20004044L/en not_active Application Discontinuation
- 2000-09-12 BG BG104759A patent/BG64911B1/en unknown
-
2004
- 2004-04-27 JP JP2004130624A patent/JP4011036B2/en not_active Expired - Fee Related
-
2007
- 2007-05-31 IL IL183596A patent/IL183596A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2365867B (en) | Vector constructs | |
| WO2002002740A3 (en) | Methods and compositions for determining gene function | |
| PA8467601A1 (en) | STREPTOMYCES AVERMITILIS GENE THAT DIRECTS THE AVERMECTIN RELATION B2: B1 | |
| AU2299999A (en) | Dnas or genes participating in parkinson's disease | |
| PA8499201A1 (en) | STREPTOMYCES AVERMITILIS GENE THAT DIRECTS THE RELATIONSHIP OF AVERMECTICINS | |
| PA8499501A1 (en) | STREPTOMYCES AVERMITILIS GENE DIRECTING THE AVERMECTIN RELATION B2: B1 | |
| CY1110454T1 (en) | STREPTOMYCES AVERMITILIS GENE THAT DEFINES THE B2: B1 | |
| CA2386587A1 (en) | Genes and proteins for the biosynthesis of anthramycin | |
| WO2002006462A3 (en) | Methylated nucleotide regulation of upa gene expression | |
| FR2766495B1 (en) | MYCOBACTERIUM STRAIN IN WHICH THE ERP GENE IS MODIFIED AND THE VACCINE COMPOSITION CONTAINING THE SAME | |
| AU2001243423A1 (en) | Random truncation and amplification of nucleic acid | |
| ES2155342B1 (en) | IMPROVEMENTS OF STREPTOMYCES STRAPS THROUGH THE USE OF BIOSYNTHETIC GENES OF TILOSINA. | |
| EP1243290A3 (en) | Modulation of gene expression by combination therapy |